ovascular
intervention for lower extremity PAD may be considered
for a one to six month course of dual antiplatelet therapy
(aspirin plus clopidogrel) to reduce the risk of MACE and
MALE followed by single antiplatelet therapy.137 Similarly,
those undergoing endovascular intervention who are not
at high risk of bleeding should be considered for aspirin
(75 e 100 mg daily) and low dose rivarox